System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Dr Ales Vicha, MD, PhD

Oncology — Charles University, Czechia

LeadR Profile

Dr Ales Vicha, MD, PhD Charles University Czechia
365 ScienceLeadR Reputation 365

Unlock

Register Login
Network Map

Oncology

Subspecialties: Neurology - Endocrinology - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1996 - 2026
Source: PubMed

University Hospital in Motol

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 131

Citations

Citations: 27 030 1st author: 9 Last author: 7 Unique author: 0

Main journals

Cell Rep 13
Cell 10
Neuro Oncol 10
Cancer Cell 6
Cesk Patol 6

Best Journals

Cell 10
J Clin Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Biogenic amines as neuroendocrine tumor markers: limitations and future perspectives.
amines, paraganglioma, laboratories, neoplasms, biogenic amines, biomarkers, neuroendocrine tumors, catecholamines, neuroblastoma		Clin Chem Lab Med20260
Pediatric ependymoma in the molecular era: real-world experience with diagnostic correlation and long-term clinical outcomes.
neoplasms, diagnosis, nervous system neoplasms, ependymoma		J Neurooncol20260
MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilities.
oncogenes, glioma, growth, insulin, biological science disciplines, somatomedins, diet, ketogenic, therapeutics		Cell Rep20260
Clinicopathological features of CIC-rearranged sarcomas: a retrospective study including novel visceral locations and methylation profile analysis.
genes, retrospective studies, pathology, sarcoma, exons		Virchows Arch20260
Harmonization of reporting for detection of ALK genetic alterations in neuroblastoma - a SIOPEN Biology study.
laboratories, therapeutics, mutation, neuroblastoma		J Mol Diagn20250

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 1
Phase 3 1

By status:

Recruiting 2

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 2

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
SIOPEN BIOPORTAL An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours
NCT05192980 — registries, blood, neoplasms, ganglioneuroblastoma, therapeutics, neuroblastoma, ganglioneuroma		N/ARecruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS